All results
7 results
-
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Trial to Evaluate the Effect of In-Hospital Initiation of Dapagliflozin on Clinical Outcomes in Patients with Heart Failure with Reduced Ejection Fraction Who Have Been Stabilized
This study will test whether the drug dapagliflozin is safe and has beneficial effects when added to conventional heart failure therapy in patients who have…
- Ages
- 18 Years - N/A
- Sexes
- All
-
A Phase 3, Multicenter, Open-Label, Single Arm Study of MR-100A-01 in Women of Childbearing Potential to Evaluate Contraceptive Efficacy and Safety
This is a study to learn the effectiveness of an investigational drug to prevent pregnancy, the safety and tolerability of wearing the patch. Healthy female…
- Ages
- 18 Years - N/A
- Sexes
- Female
-
A Phase 3, multi-centre long-term extension study to assess the safety and efficacy of GSK3196165 in the treatment of rheumatoid arthritis.
This is a long-term extension study of up to about 4 years for people with RA who may benefit from extended treatment with otilimab, after completing the…
- Ages
- 18 Years - N/A
- Sexes
- All
-
CGUARD – An Investigation of a Neuroprotective Stent A Multicenter, Single-Arm, Pivotal Study to Evaluate the Safety and Efficacy of the CGuard™ Carotid Stent System When Used to Treat Symptomatic and Asymptomatic Carotid Artery Stenosis in Patients
This clinical trial is being done to help evaluate a new investigational device to treat narrowing of the carotid arteries in the neck. The device is called…
- Ages
- 18 Years - N/A
- Sexes
- All
-
EVOLVE-MI: A Pragmatic Randomized Multicenter Trial of EVOLocumab Administered Very Early to Reduce the Risk of Cardiovascular Events in Patients Hospitalized With Acute Myocardial Infarction (20222099)
This study is being done to learn whether regular healthcare, combined with early treatment with a cholesterol lowering drug called evolocumab (Repatha®)…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Precision Cancer Survivorship Cohort
People diagnosed with cancer frequently experience long-term health conditions earlier in life when compared to their non-cancer peers; many of these long-term…
- Ages
- 18 Years - N/A
- Sexes
- All
-
Selatogrel Outcome Study in suspected Acute Myocardial Infarction (SOS-AMI)
Multi-center, double-blind, randomized, placebo-controlled, parallel-group study to evaluate the efficacy and safety of self-administered subcutaneous…
- Ages
- 18 Years - N/A
- Sexes
- All